Theragenics Corporation (TGX) Announces Stockholder Approval of Merger Agreement With Juniper
10/17/2013 10:58:18 AM
BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation® (NYSE: TGX) (the “Company”), a medical device company serving the surgical products and prostate cancer treatment markets, announced today that the stockholders of the Company voted to approve the previously announced merger agreement providing for a newly formed affiliate of Juniper Investment Company, LLC to acquire all of the outstanding common stock of the Company for $2.20 per share in cash.
Help employers find you! Check out all the jobs and post your resume.
comments powered by